Solid Biosciences Inc (SLDB)
10.10
-0.13
(-1.27%)
USD |
NASDAQ |
May 03, 16:00
10.18
+0.08
(+0.84%)
After-Hours: 20:00
Solid Biosciences Profit Margin (Quarterly)
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
Date | Value |
---|---|
June 30, 2022 | -406.7% |
March 31, 2022 | -1.32K% |
December 31, 2021 | -590.0% |
Date | Value |
---|---|
September 30, 2021 | -508.4% |
June 30, 2021 | -520.2% |
March 31, 2021 | -506.7% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
-1.32K%
Minimum
Mar 2022
-406.7%
Maximum
Jun 2022
-641.3%
Average
-514.3%
Median
Profit Margin (Quarterly) Benchmarks
Sarepta Therapeutics Inc | 8.74% |
PTC Therapeutics Inc | -43.58% |
Capricor Therapeutics Inc | -6.30% |
Perspective Therapeutics Inc | -- |
Electromed Inc | 12.23% |